CLINICAL_TRIALS
trial_result
· 2021-09-23
Clinical Trial Update: Predictors of Lorcaserin-Induced Weight Loss [Phase 4]
Summary
Phase 4 trial assessing predictors of weight loss with lorcaserin in overweight and obese individuals; study terminated with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Overweight and Obesity | Phase 4 | Status: TERMINATED | Results posted: 2021-09-23